![Local administration of ACE-083 in wild-type mice causes dose-dependent... | Download Scientific Diagram Local administration of ACE-083 in wild-type mice causes dose-dependent... | Download Scientific Diagram](https://www.researchgate.net/publication/335000117/figure/fig1/AS:788899634872326@1565099738797/Local-administration-of-ACE-083-in-wild-type-mice-causes-dose-dependent-growth-of-the_Q640.jpg)
Local administration of ACE-083 in wild-type mice causes dose-dependent... | Download Scientific Diagram
![FDA Grants Orphan Drug Designation to Acceleron Pharma's ACE-083 Muscle Growth Drug for Charcot-Marie-Tooth Disease - Quest | Muscular Dystrophy Association FDA Grants Orphan Drug Designation to Acceleron Pharma's ACE-083 Muscle Growth Drug for Charcot-Marie-Tooth Disease - Quest | Muscular Dystrophy Association](https://mdaquest.org/wp-content/uploads/2022/05/iStock-916966528-18-scaled-e1652326047635-1024x512.jpg)
FDA Grants Orphan Drug Designation to Acceleron Pharma's ACE-083 Muscle Growth Drug for Charcot-Marie-Tooth Disease - Quest | Muscular Dystrophy Association
![Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy - Saitoh - 2017 - JCSM Clinical Reports - Wiley Online Library Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy - Saitoh - 2017 - JCSM Clinical Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cfa6b09c-00ab-4cd1-950b-817b2f802355/crt2002001006-fig-0001-m.jpg)
Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy - Saitoh - 2017 - JCSM Clinical Reports - Wiley Online Library
![ACE-083 1000 mcg muscular dystrophy research - SuperhumanStore - longevity, dutasteride mesotherapy, NAD+, peptides, Cerebrolysin, exosomes, anti-aging, senolytics ACE-083 1000 mcg muscular dystrophy research - SuperhumanStore - longevity, dutasteride mesotherapy, NAD+, peptides, Cerebrolysin, exosomes, anti-aging, senolytics](https://i0.wp.com/www.superhumanstore.com/shg/wp-content/uploads/2014/10/vial_blank_bluetop.jpg)
ACE-083 1000 mcg muscular dystrophy research - SuperhumanStore - longevity, dutasteride mesotherapy, NAD+, peptides, Cerebrolysin, exosomes, anti-aging, senolytics
![Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy - Statland - 2022 - Muscle & Nerve - Wiley Online Library Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy - Statland - 2022 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a5d7d5ba-a281-48b2-825a-579aa3223451/mus27558-fig-0003-m.jpg)
Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy - Statland - 2022 - Muscle & Nerve - Wiley Online Library
![Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy - Statland - 2022 - Muscle & Nerve - Wiley Online Library Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy - Statland - 2022 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/19616d12-4bc4-46d4-8755-8ba63d667020/mus27558-fig-0002-m.jpg)